By Sabela Ojea


The Oncology Institute is buying back 2 million shares of its common stock, the company said in a Securities and Exchange Commission filing Wednesday.

Its board of directors approved the share-repurchase program Monday.

The institute didn't provide details on what motivated it to repurchase the stock.


Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix


(END) Dow Jones Newswires

08-30-23 1611ET